416 related articles for article (PubMed ID: 12446231)
1. [Relevance of cytological and immunophenotypical analysis for the diagnosis of B-cell chronic lymphocytic leukaemia].
Guillaume N; Alimardani G; Capiod JC; Claisse JF
Ann Biol Clin (Paris); 2002; 60(6):673-81. PubMed ID: 12446231
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
3. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
4. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
5. Adhesion molecules in B-chronic lymphoproliferative disorders.
Angelopoulou MK; Kontopidou FN; Pangalis GA
Semin Hematol; 1999 Apr; 36(2):178-97. PubMed ID: 10319387
[TBL] [Abstract][Full Text] [Related]
6. [Question of differential diagnosis in a case of chronic B-cell lymphopathy].
Moccia F; Casti P; Morra L
Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525
[TBL] [Abstract][Full Text] [Related]
7. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
[TBL] [Abstract][Full Text] [Related]
8. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
[TBL] [Abstract][Full Text] [Related]
9. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
Schwarze EW
Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
[TBL] [Abstract][Full Text] [Related]
10. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
[TBL] [Abstract][Full Text] [Related]
11. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of flow cytometry in the chronic lymphoid leukemias.
DiGiuseppe JA; Borowitz MJ
Semin Oncol; 1998 Feb; 25(1):6-10. PubMed ID: 9482521
[TBL] [Abstract][Full Text] [Related]
13. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
14. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
[TBL] [Abstract][Full Text] [Related]
15. Chronic B-cell lymphoproliferative disease: relationship between immunophenotype and clinical stage.
Dazzi F; Veronesi A; D'Andrea E; Sgarabotto D; Girolami A
Haematologica; 1990; 75(3):243-8. PubMed ID: 2227621
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
17. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
[TBL] [Abstract][Full Text] [Related]
18. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
19. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
20. CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma.
Jevremovic D; Dronca RS; Morice WG; McPhail ED; Kurtin PJ; Zent CS; Hanson CA
Leuk Res; 2010 Sep; 34(9):1235-8. PubMed ID: 20362334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
